Improving Survival in Decompensated Cirrhosis

被引:20
作者
Mukerji, Amar Nath [1 ]
Patel, Vishal [2 ]
Jain, Ashokkumar [1 ]
机构
[1] Temple Univ Hosp & Med Sch, Dept Surg, Liver Transplant Program, 3401 N Broad St,Suite C640 Parkinson Pavillion, Philadelphia, PA 19140 USA
[2] Temple Univ Hosp & Med Sch, Dept Med, Hepatol Serv, Philadelphia, PA 19140 USA
关键词
D O I
10.1155/2012/318627
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mortality in cirrhosis is consequent of decompensation, only treatment being timely liver transplantation. Organ allocation is prioritized for the sickest patients based on Model for End Stage Liver Disease (MELD) score. In order to improve survival in patients with high MELD score it is imperative to preserve them in suitable condition till transplantation. Here we examine means to prolong life in high MELD score patients till a suitable liver is available. We specially emphasize protection of airways by avoidance of sedatives, avoidance of Bilevel Positive Airway Pressure, elective intubation in grade III or higher encephalopathy, maintaining a low threshold for intubation with lesser grades of encephalopathy when undergoing upper endoscopy or colonoscopy as pre transplant evaluation or transferring patient to a transplant center. Consider post-pyloric tube feeding in encephalopathy to maintain muscle mass and minimize risk of aspiration. In non intubated and well controlled encephalopathy, frequent physical mobility by active and passive exercises are recommended. When renal replacement therapy is needed, night-time Continuous Veno-Venous Hemodialysis may be useful in keeping the daytime free for mobility. Sparing and judicious use of steroids needs to be borne in mind in treatment of ARDS and acute hepatitis from alcohol or autoimmune process.
引用
收藏
页数:14
相关论文
共 146 条
[1]   A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites [J].
Albillos, A ;
Bañares, R ;
González, M ;
Catalina, MV ;
Molinero, LM .
JOURNAL OF HEPATOLOGY, 2005, 43 (06) :990-996
[2]   MELD score and clinical type predict prognosis in hepatorenal syndrome:: Relevance to liver transplantation [J].
Alessandria, C ;
Ozdogan, O ;
Guevara, M ;
Restuccia, T ;
Jiménez, W ;
Arroyo, V ;
Rodés, J ;
Ginès, P .
HEPATOLOGY, 2005, 41 (06) :1282-1289
[3]  
Alvarez M. A., 2011, J CLIN GASTROENTEROL
[4]   Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis [J].
Amitrano, L ;
Guardascione, MA ;
Brancaccio, V ;
Margaglione, M ;
Manguso, F ;
Iannaccone, L ;
Grandone, E ;
Balzano, A .
JOURNAL OF HEPATOLOGY, 2004, 40 (05) :736-741
[5]   β-Blockers and refractory ascites in cirrhosis: The message of a team of true scientists [J].
Angeli, Paolo .
JOURNAL OF HEPATOLOGY, 2011, 55 (04) :743-744
[6]  
Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122
[7]   Pathogenesis and treatment of hepatorenal syndrome [J].
Arroyo, Vicente ;
Fernandez, Javier ;
Gines, Pere .
SEMINARS IN LIVER DISEASE, 2008, 28 (01) :81-95
[8]   PROGNOSTIC-SIGNIFICANCE OF BACTERIAL-INFECTION IN BLEEDING CIRRHOTIC-PATIENTS - A PROSPECTIVE-STUDY [J].
BERNARD, B ;
CADRANEL, JF ;
VALLA, D ;
ESCOLANO, S ;
JARLIER, V ;
OPOLON, P .
GASTROENTEROLOGY, 1995, 108 (06) :1828-1834
[9]   Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding:: A meta-analysis [J].
Bernard, B ;
Grangé, JD ;
Khac, EN ;
Amiot, X ;
Opolon, P ;
Poynard, T .
HEPATOLOGY, 1999, 29 (06) :1655-1661
[10]   Serum sodium predicts mortality in patients listed for liver transplantation [J].
Biggins, SW ;
Rodriguez, HJ ;
Bacchetti, P ;
Bass, NM ;
Roberts, JP ;
Terrault, NA .
HEPATOLOGY, 2005, 41 (01) :32-39